» Articles » PMID: 25555374

The Characterization of the Human Cell Line Calu-3 Under Different Culture Conditions and Its Use As an Optimized in Vitro Model to Investigate Bronchial Epithelial Function

Overview
Journal Eur J Pharm Sci
Specialties Chemistry
Pharmacology
Date 2015 Jan 4
PMID 25555374
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

In this study we have investigated the effects of different cell culture conditions on the Calu-3 epithelial cell model. Calu-3 cells were cultured in media A-MEM at the air-liquid (A-L) or liquid-liquid (L-L) interface for one or three wks (weeks). Different cryomethods were tested and the cell line was characterized using histochemistry, immunofluorescence, transmission and scanning electron microscopy, transepithelial resistance (TEER) measurements, permeability studies, and gene profiling of 84 drug transporters. Cell culture was successful in A-MEM with only 2.5% FBS. Cell proliferation and viability depended on the cryopreservation method. All Calu-3 models expressed CK7, occludin, and E-cadherin. The A-L interface resulted in a more biomimetic native bronchial epithelium displaying pseudostratified columnar epithelium with more microvilli and secretory vesicles than at the L-L interface, where the epithelium was cuboidal, but exhibited higher TEER values and lower dextran permeabilities. Longer time in culture significantly decreased dextran permeability and increased the expression of specific drug transporters. Drug transporter expression was also notably influenced by the culture interface, where the A-L interface yielded a higher expression of drug transporter genes than the L-L interface. Since cell culture interface and time in culture affect Calu-3 cell differentiation, barrier integrity, permeability properties, and drug transporter expression, culture conditions need to be considered and standardized when using the Calu-3 cell line as an in vitro model for aerosol drug delivery and screening of bronchial drug candidates.

Citing Articles

HMOS 2'FL and 3FL prevent house dust mite induced proinflammatory cytokine release and decrease specific IgE production in a murine allergic asthma model.

Zuurveld M, de Kleer J, Berends A, Kooy M, Van Ark I, Leusink-Muis T Front Nutr. 2025; 12:1491430.

PMID: 40046758 PMC: 11879794. DOI: 10.3389/fnut.2025.1491430.


In Vitro and In Vivo Assessment of Pharmacokinetic Profile of Peramivir in the Context of Inhalation Therapy.

Dong L, Hu J, Zhang Q, Yang M, Zhang W, Zhuang X Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005995 PMC: 11858854. DOI: 10.3390/ph18020181.


Two- and Three-Dimensional Culture Systems: Respiratory In Vitro Tissue Models for Chemical Screening and Risk-Based Decision Making.

Wallace J, McElroy M, Klausner M, Corley R, Ayehunie S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861174 PMC: 11768377. DOI: 10.3390/ph18010113.


A Dynamic Breathing Lung Chip for Precise Evaluation of Inhaled Drug Efficacy and Airway Epithelial Responses.

Liu C, Chen Y, Mu H, Huang J ACS Biomater Sci Eng. 2024; 11(1):682-691.

PMID: 39616618 PMC: 11733924. DOI: 10.1021/acsbiomaterials.4c01377.


Dissecting the role of the HA1-226 leucine residue in the fitness and airborne transmission of an A(H9N2) avian influenza virus.

Sun X, Belser J, Pulit-Penaloza J, Brock N, Kieran T, Pappas C J Virol. 2024; 98(12):e0092824.

PMID: 39495016 PMC: 11651004. DOI: 10.1128/jvi.00928-24.